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Dietary bioactive components that play a role in improving skeletal health have received considerable attention in complementary
and alternative medicine practices as a result of their increased eﬃcacy to combat chronic diseases. The objectives of this study
were to evaluate the additive or synergistic eﬀects of dried plum and fructooligosaccharides (FOS) and to determine whether dried
plum and FOS or their combination in a soy protein-based diet can restore bone mass in ovarian hormone deﬁcient rats. For this
purpose, 72 3-month-old female Sprague-Dawley rats were divided into six groups (n = 12) and either ovariectomized (Ovx, ﬁve
groups) or sham-operated (sham, one group). The rats were maintained on a semipuriﬁed standard diet for 45 days after surgery
to establish bone loss. Thereafter, the rats were placed on one of the following dietary treatments for 60 days: casein-based diet
(Sham and Ovx), soy-based diet (Ovx + soy) or soy-based diet with dried plum (Ovx + soy + plum), FOS (Ovx + soy + FOS) and
combinationofdriedplumandFOS(Ovx+soy+plum+FOS).Soyproteinincombinationwiththetestcompoundssigniﬁcantly
improved whole-body bone mineral density (BMD). All test compounds in combination with soy protein signiﬁcantly increased
femoral BMD but the combination of soy protein, dried plum and FOS had the most pronounced eﬀect in increasing lumbar
BMD. Similarly, all of the test compounds increased ultimate load, indicating improved biomechanical properties. The positive
eﬀects of these test compounds on bone may be due to their ability to modulate bone resorption and formation, as shown by
suppressed urinary deoxypyridinoline excretion and enhanced alkaline phosphatase activity.
1.Introduction
The postmenopausal period typically occupies one-third of
a woman’s life [1], with more than 45.6 million women in
the United States in the postmenopausal phase [2]. As the
demographic shift to a more aged population continues,
a growing number of people will be aﬄicted with osteoporo-
sis [3]. Currently, pharmaceutical therapies, for example,
bisphosphonates, calcitonin and parathyroid hormone, have
low long-term compliance and are cost prohibitive [4, 5].
Therefore, further exploration of alternatives and/or adjunc-
tive approaches that can produce clinically relevant bone
sparing eﬀects would be of interest. Complementary and
alternative medicine (CAM) strategies including biologically
based practices such as botanicals and prebiotics have
recently become more mainstream due to suggestions by
conventional health care providers and consumer belief that
CAM treatments will be more eﬀective in combating their
health care problem compared with prescription drugs.
Conventional health care providers often administer
several medications focusing on the pathogenic process of
osteoporosis rather than seeking alternatives that maximize
the inherent healing ability of a person’s body. As a result,
considerable interest has been generated recently by the
desire of postmenopausal women to ﬁnd more natural ways
to combat osteoporosis. Scientists have turned to explore
the health beneﬁts of plant-based bioactive compounds
because they contain vitamins and minerals that are essential2 Evidence-Based Complementary and Alternative Medicine
to bone health and a number of synthetic and natural
phytochemicals that have been shown to positively inﬂu-
ence bone metabolism. For instance, soy protein and its
isoﬂavones have been shown to improve bone mass in both
animal models of osteoporosis [6–8] and pre- and post-
menopausal women [9–11]. Studies from our laboratory
have demonstrated that dried plum eﬀectively prevents
and/or reverses bone loss in rat models of osteoporo-
sis [12–14] and positively inﬂuences biomarkers of bone
metabolismin postmenopausal women [15]. Recently, we
have reported that fructooligosaccharide (FOS), a prebiotic,
reverses bone loss in ovariectomized rats [16]. The positive
resultsofourpreviousworkwarrantexaminationofwhether
a combination of these bioactive components, for example,
combining soy with dried plum or soy with both dried plum
andFOS,providesasynergisticeﬀect.Thegoalofthepresent
study was to investigate the extent to which the combination
of various bioactive compounds reverses bone loss in an
ovariectomized rat model of osteoporosis.
2. Methods
2.1. Animals and Diets. Seventy-two female, 3-month-old
Sprague–Dawley rats (Harlan Sprague-Dawley Inc., Indi-
anapolis, IN) were individually housed in an environmen-
tally controlled facility. Guidelines for the ethical care and
treatment of animals from the Animal Care and Use Com-
mittee at Oklahoma State University were strictly followed.
After 5 days of acclimation, the rats were divided into six
groups (n = 12/group) and either ovariectomized (Ovx, 5
groups) or sham-operated (sham, 1 group). Prior to surgery,
whole-body bone mineral content (BMC) and bone min-
eral density (BMD) were assessed using dual-energy X-ray
absorptiometry(DXA;QDR4500AElitemodel,HologicInc.,
Bedford, MA). Thereafter, rats were maintained on AIN-
93M (Research Diets, New Brunswick, NJ), a semipuriﬁed,
powdered casein-based diet, for 45 days to induce bone loss.
After bone loss was conﬁrmed, the sham group and one Ovx
group continued to receive the same casein-based diet and
served as controls. The remaining four Ovx groups were fed
the following diet: (i) Ovx + soy; (ii) soy + 7.5% dried plum,
(iii) soy + 5% FOS and (iv) soy + 7.5% dried plum + 5%
FOS. All diets were adjusted to have equivalent amount of
carbohydrate, protein, fat, ﬁber, total energy, calcium and
phosphorus; furthermore, in the soy treatment group, casein
was replaced with soy protein. Rats were pair-fed to the
average food intake of the sham group and had free access
to deionized water. Food intake was recorded every 3 days,
and body weight was measured weekly.
2.2. Animal Necropsy and Processing of Samples. One day
prior to necropsy, rats were placed in metabolic cages and
urine was collected. At the end of the 60 day treatment
period, rats were anesthetized with a mixture of ketamine
andxylazine(100and5mgkg−1 bodyweight,resp.)andbled
from the abdominal aorta. Blood samples were collected,
and serum was separated by centrifugation at 1500g for
20min at 4◦C. Aliquots of serum and urine were frozen
and kept at −20
◦C for later analyses. The femurs, tibiae
and fourth lumbar vertebrae were removed, cleaned and
freed of surrounding soft tissues. The left tibiae were stored
in 70% ethanol for histomorphometric analyses while the
other bones were frozen at −20
◦C until analyses. Uteri were
collected, blotted and weighed to conﬁrm the success of
ovariectomy.
2.3. Biochemical Analyses of Serum and Urine. A commer-
cially available radioimmunoassay kit was used to measure
serum 17 β-estradiol (E2) (Diagnostic Products Corp.,
Los Angeles, CA). The intra- and interassay coeﬃcient
of variation (CV) was 3.9 and 4.9% for E2. Serum total
alkaline phosphatase (ALP) activity and urinary creatinine
were determined colorimetrically using commercially avail-
able kits from Roche Diagnostics (Branchburg, NJ). These
colorimetrictestswereperformedonaCobas-FaraIIClinical
Analyzer (Montclair, NJ). Urinary deoxypyridinoline (Dpd)
was measured by competitive enzyme immunoassay in
a microassay stripwell format (Quidel Corporation, Moun-
tain View, CA). The intra- and interassay CVs were 1.9 and
2.8%, 1.7 and 6.3% and 4.3 and 4.6% for ALP, creatinine and
Dpd, respectively.
2.4. Bone Mineral Density (BMD) and Mineral Content
(BMC). BMD and BMC of the whole body, right femurs
andfourthlumbarvertebraewereassessedbyDXAequipped
with appropriate software for use with small laboratory
animals and isolated bones. Whole-body BMD and BMC
were assessed the day of the surgery, 45 days after surgery
to assure that bone loss has occurred due to ovariectomy
and at the end of 60 days of dietary treatment for evaluating
treatment eﬀects. To ash the bones, they were dried, weighed
and placed in a muﬄe furnace at 600
◦C for 24h. For
assessing total mineral content, the amount of ash was
weighed and values were reported as percent ash.
2.5. Biomechanical Testing of the Left Femur. Femoral
strength was assessed by three-point bending performed
on a material testing system (Instron 5543, Canton, MA).
The femur was placed in a three-point bending ﬁxture
such that the posterior surface rests on the lower supports
and the upper support touches the anterior surface. One
lower support was placed touching the posterior surface
at the distal end of the femur, at the point where the
metaphysis begins to widen, 5–8mm from the distal end.
During this test, the anterior surface was under compression
and the posterior surface was under tension. An initial load
(∼10N) was applied to stabilize the specimen. The three-
point bending test was performed at a displacement rate
of 3mm min−1. The load–displacement curve was recorded
simultaneously during the test.
After the mechanical test, the cross-sectional surface at
the fracture site was prepared ﬂat for tracing and subsequent
inertial and area calculations. The ultimate load, yield load
and the stiﬀness of the specimen were measured from the
load-displacement curve. Ultimate stress, yield stress and
modulus of elasticity of the specimen were calculated usingEvidence-Based Complementary and Alternative Medicine 3
Table 1: Eﬀects of ovariectomy (Ovx) and various dietary treatments on food intake and body and uterine weights.
Parameters Sham-casein Ovx + casein Ovx + soy Ovx + soy + plum Ovx + soy+ FOS Ovx + soy + plum + FOS
Food intake (g/d) 14.1 ± 0.4 14.0 ± 0.3 13.9 ± 0.3 13.9 ± 0.3 14.1 ± 0.4 14.2 ± 0.3
Body weights (g)
Initial 231 ± 1 231 ± 1 232 ± 1 231 ± 1 230 ± 1 232 ± 1
Final 281 ± 4b 317 ± 4a 315 ± 4a 319 ± 4a 327 ± 4a 316 ± 4a
Uterine weight (mg) 606 ± 33a 185 ± 31b 182 ± 30b 169 ± 30b 132 ± 31b 141 ± 31b
Values are mean ± SE; n = 12. Within a row, values that do not share the same superscript letters are signiﬁcantly (P<. 05) diﬀerent from each other.
beam-bending theory using values for second moment of
area.
2.6. Bone Histomorphometry. A t8d a y sa n da t1d a yp r i o r
to necropsy, rats were subcutaneously injected with cal-
cein (8mgkg−1 body weight; Sigma, St Louis, MO) for
double-ﬂurochrome labeling of bone to determine active
mineralization sites and rate of bone formation using
histomorphometry. Quantitative histomorphometry of the
left tibia was used to examine the dynamics of the bone
changes and bone cell activities due to ovariectomy and
dietary treatments.
The tibiae were cut at 1mm distal to the tibio-ibula
junction (TFJ) and 19mm proximal to the TFJ to obtain
a proximal portion for cancellous bone histomorphometry.
Both the central diaphysis and proximal tibia were placed in
Villanueva stain for 72 h and then returned to 70% ethanol.
During the next 14 days, the specimens were dehydrated in
graded ethanol and acetone and then embedded individually
in modiﬁed methyl methacrylate. Sections were analyzed
with a light/epiﬂuorescent microscope and a video camera
interfaced with the BIOQUANT TCW software (R&M
Biometrics, Nashville, TN).
3.StatisticalAnalysis
Data analyses involved computation of means and SEM
for each of the treatment groups using SAS (Version 8.2,
SAS Institute, Cary, NC). Analysis of variance and least
square means were calculated using the general linear model
procedure and the means were compared using Fisher’s least
signiﬁcantdiﬀerenceforcomparinggroups.Diﬀerenceswere
considered signiﬁcant at P < .05.
4. Results
4.1. Food Intake, Body and Uterine Weights. The success of
the surgical procedure was conﬁrmed as the rats in Ovx
groups experienced atrophy of uterine tissue (Table 1). Rats
in various treatment groups started with similar body weight
and were pair-fed to the average food intake of the Sham
group throughout the course of the study. However, in spite
of pair feeding, the ﬁnal mean body weight of rats in all Ovx
groups was signiﬁcantly higher than that in the Sham group.
4.2. Whole-Body BMD and BMC. Whole-body BMD and
BMC prior to Ovx were not diﬀerent among the groups
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Figure 1: Eﬀects of ovariectomy (Ovx) and various dietary
treatments on change in whole-body bone mineral density (BMD).
Bars represent mean + SE; n = 12 rats per group. Bars with diﬀerent
letters are signiﬁcantly (P < .05) diﬀerent from each other.
(data not shown). However, 45 days after ovariectomy, all
Ovx rats on average had 5% lower (P < .05) whole-body
BMD compared with the sham rats (data not shown). After
60 days of dietary treatment, Ovx rats that were fed soy
protein combined with FOS alone (Ovx + soy + FOS) or in
combination with dried plum (Ovx + soy + plum + FOS)
had signiﬁcantly higher whole-body BMD when compared
with casein-fed Ovx rats, although not quite to the level
of the Sham rats (Table 2). Soy protein alone (Ovx + soy)
or in combination with dried plum (Ovx + soy + plum)
did not improve whole-body BMD (Table 2). When we
calculated the change in whole-body BMD (diﬀerence in
BMD values before and after dietary treatment), soy protein
diet in combination with any of the bioactive compounds
causedasigniﬁcantlyhighergaininwhole-bodyBMDinrats
compared with those receiving casein or soy protein alone
(Figure 1).
4.3. Femoral and Fourth Lumbar BMD and BMC. The
right femoral BMC and BMD were signiﬁcantly reduced in
ovariectomized rats in comparison with intact rats (Table 2).
Animals on the soy + FOS treatment had femoral BMC
similar to the sham animals and signiﬁcantly higher than
the Ovx rats receiving the casein-based diet. Dried plum in
the diet (Ovx + soy + plum or Ovx + soy + plum + FOS)4 Evidence-Based Complementary and Alternative Medicine
Table 2: Eﬀects of ovariectomy (Ovx) and various dietary treatments on whole body, right femur and fourth lumbar BMD and BMC.
Parameters Sham-casein Ovx + casein Ovx + soy Ovx + soy + plum Ovx + soy + FOS Ovx + soy + plum + FOS
Whole body
BMC (g) 10.268 ± 0.164 10.397 ± 0.164 10.297 ± 0.157 10.648 ± 0.157 10.779 ± 0.164 10.625 ± 0.164
BMD (mg/cm2) 172.4 ± 1.4a 159.8 ± 1.4c 161.4 ± 1.4c 165.2 ± 1.4b,c 167.2 ± 1.4b 167.5 ± 1.4b
Right femur
BMC (mg) 473.9 ± 8.8a 435.0 ± 8.8c 447.5 ± 8.4b,c 450.1 ± 8.4a,b,c 464.6 ± 8.8a,b 454.9 ± 6.4a,b,c
BMD (mg/cm2) 250.7 ± 2.5a 226.2 ± 2.5c 232.9 ± 2.4b,c 235.5 ± 2.4b 238.2 ± 2.5b 237.5 ± 2.5b
Ash (%) 68.2 ± 0.5a 66.6 ± 0.5b 65.9 ± 0.5b 66.8 ± 0.5a,b 67.2 ± 0.5a,b 66.3 ± 0.5b
Fourth Lumbar
BMC (mg) 152.4 ± 3.7a 128.4 ± 3.7d 131.5 ± 3.6c,d 138.5 ± 3.6b,c,d 142.0 ± 3.7b 140.7 ± 3.7b,c
BMD (mg/cm2) 246.2 ± 3.8a 215.0 ± 3.8d 219.7 ± 3.7c,d 222.5 ± 3.7c,d 228.1 ± 3.8b,c 232.3 ± 3.8b
Ash (%) 63.3 ± 0.6a 56.3 ± 0.6c 57.0 ± 0.6b,c 58.5 ± 0.6b 58.5 ± 0.6b 58.7 ± 0.6b
Values are mean ± SE; n = 12. Within a row, values that do not share the same superscript letters are signiﬁcantly (P<. 05) diﬀerent from each other.
increased femoral BMC to the levels of the sham animals
but still similar to the Ovx rats receiving the casein-based
diet. In Ovx rats, in terms of BMD, addition of any of the
bioactive compounds to a soy protein-based diet resulted in
a signiﬁcantly higher femoral BMD compared with casein,
albeit not to the level of the intact rats (Table 2). The Ovx-
induced reduction in total mineral content (% ash) of the
right femur was modulated by the addition of FOS (Ovx +
soy + FOS) or dried plum alone to soy protein-based diet
but not their combination (Ovx + soy + plum + FOS).
Similar to the femur, ovariectomy signiﬁcantly reduced
BMC, BMD and % ash of the fourth lumbar, a site mostly
composed of trabecular bone (Table 2). In Ovx rats, the
decrease in these parameters due to ovariectomy was mod-
ulated by soy-protein diet with added bioactive component
but not quite to the level of sham rats. Ovariectomized rats
fed the combination of soy, dried plum and FOS (Ovx +
soy + plum + FOS) have the highest fourth lumbar BMD,
but again, not quite to the level of sham rats.
4.4. Biomechanical Properties of the Left Femur. In Ovx rats,
ovariectomy somewhat reduced ultimate load, an indicator
of the material properties of bone, compared with sham
rats (Figure 2). However, femurs of ovariectomized rats fed
a soy protein-based diet with added FOS (Ovx + soy +
FOS) withstood the greatest loads. There were no signiﬁcant
changes in other biomechanical properties such as yield
load, stiﬀness, ultimate stress, yield stress and modulus of
elasticity due to ovariectomy or dietary interventions (data
not shown).
4.5. Histomorphometric Analyses of the Tibia. Ovariectomy
caused an increase in trabecular thickness (Tb Th), trabecu-
larseparation(TbSp)andmineralsurfaceaspercentofbone
surface (MS/BS) (Table 3). Any of the diets containing FOS
slightly improved Tb Sp to the sham level but still similar
to the Ovx control rats. Ovariectomized rats receiving diets
containing the combination of soy with dried plum (Ovx +
soy + plum) had Tb Th values that were moderately brought
down to levels similar to those of intact rats, yet still high
enoughtoalsobesimilartothoseobservedintheOvxgroup.
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Figure 2: Eﬀects of ovariectomy (Ovx) and various dietary
treatmentsonultimateloadoftheleftfemur.Barsrepresentmean+
SE; n = 12 rats per group. Bars with diﬀerent letters are signiﬁcantly
(P < .05) diﬀerent from each other.
Diets containing the combination of soy with plum and FOS
(Ovx + soy + plum + FOS) reduced MS/BS to the sham level.
Trabecular number was decreased due to ovariectomy and
dietary treatments did not prevent the ovariectomy-induced
decrease on this parameter.
4.6. Serum and Urine Analyses. As expected, ovariectomy
signiﬁcantly reduced serum levels of E2, thus conﬁrming
the success of the surgery (Table 4). Ovariectomy slightly
increasedserumALPactivityandsoyproteinincombination
with dried plum (Ovx + soy + plum) or FOS (Ovx + soy +
FOS) further increased serum ALP activity. Ovariectomized
rats receiving the casein-based diet had signiﬁcantly higher
excretion of urinary Dpd, a speciﬁc marker of bone resorp-
tion, compared with intact rats. This increase in urinary
Dpd excretion was ameliorated to levels similar to those
of sham rats by all of the soy protein-based diets except
the combination of soy with dried plum (Ovx + soy +
plum), which produced an intermediate eﬀect. This ﬁndingEvidence-Based Complementary and Alternative Medicine 5
Table 3: Eﬀects of ovariectomy (Ovx) and various dietary treatments on histomorphometric parameters of the left proximal tibia.
P a r a m e t e r s S h a m - c a s e i n O v x+c a s e i n O v x+s o y O v x+s o y+p l u m O v x+s o y+F O S O v x+s o y+p l u m+F O S
BV/TV (%) 11.9 ± 1.9a 8.1 ± 1.9a,b 6.7 ± 1.9a,b 5.2 ± 1.9b 8.3 ± 1.9a,b 9.9 ± 1.9a,b
Tb Th (μm) 46 ± 5c 63 ± 5a,b 58 ± 5a,b,c 53 ± 5b,c 61 ± 5a,b 69 ± 5a
Tb N (n)2 . 4 6 ± 0.27a 1.09 ± 0.27b 1.19 ± 0.27b 0.99 ± 0.27b 1.26 ± 0.27b 1.42 ± 0.27b
Tb Sp (μm) 441 ± 198b 1359 ± 198a 1032 ± 198a 1125 ± 198a 959 ± 198a,b 942 ± 198a,b
MS/BS (%) 2.2 ± 2.0b 10.2 ± 2.0a 10.1 ± 2.0a 8.9 ± 2.0a 12.1 ± 2.0a 6.5 ± 2.0ab
Values are mean ± SE; n = 6. Within a row, values that do not share the same superscript letters are signiﬁcantly (P<. 05) diﬀerent from each other. BV/TV =
bone volume as percentage of tissue volume; Tb N = trabecular number.
indicated that the combinations of these dietary components
increased the ovariectomy-induced rate of bone formation
while reducing the ovariectomy-induced increase in bone
resorption.
5. Discussion
Inhibiting further bone loss and reducing the risk of frac-
ture are hallmarks for an eﬀective antiosteoporotic agent.
Although there are a number of conventional medicines for
preventing and/or treating osteoporosis, these medicines are
n o td e v o i do fs i d ee ﬀects and are also costly. In addition,
the long-term patient adherence rates are low. The purpose
of our research is to ﬁnd functional foods that can act as
such agents by preventing bone loss or promoting bone
restoration. The present study was designed to determine if
combining soy protein with FOS, dried plum or both was
more eﬀective at restoring bone loss as a result of ovarian
hormone deﬁciency.
The ﬁndings of this study show that while a soy protein-
based diet alone was not suﬃcient to reverse the loss
in whole-body, femoral and fourth lumbar BMD due to
ovariectomy, the combination of soy protein with other
b i o a c t i v ec o m p o n e n t ss u c ha sF O Sa n dd r i e dp l u mw a sa b l e
to improve BMD of osteopenic Ovx rats. Soy protein alone
oﬀersminimalbeneﬁcialeﬀectonBMDwhileFOSanddried
plum provide additive eﬀects in terms of bone density in this
animal model. In general, the eﬀect of soy protein on bone is
controversial and inconclusive. Soy protein has been shown
to have no signiﬁcant eﬀect [10, 17–21] or a slight increase
[7, 8, 11, 22, 23] in BMD in both animal studies and small
clinical trials. Its eﬃcacy however is awaiting conﬁrmation
via large clinical trials that are currently underway.
Thehigherwhole-bodyBMDindietssupplementedwith
FOS (Ovx + soy + FOS, Ovx + soy + FOS + plum) suggests
that FOS, a mixture of indigestible and fermentable sugars,
has a bone reversal eﬀect. FOS has been shown to increase
absorption of minerals from the colon [24–26] and increase
calcium balance and bone mineralization, as well as decrease
boneturnoverrateinOvxrats[27]andmice[28].Ithasbeen
reported that FOS can maximize the bone sparing eﬀects of
soy–isoﬂavone enriched diet in Ovx rats by modulating the
bioavailability of isoﬂavones [27, 29]. In the present study,
we observed that the rats receiving FOS plus soy had higher
levels of serum ALP and femurs that withstood greatest load
strain. Increased bone density may lead to enhanced bone
strength, reducing the risk of fracture, which is evident in
the soy plus FOS diet due to greater whole-body BMD and
greatest load strain tolerance.
Combining FOS and dried plum signiﬁcantly improved
whole-body BMD, femoral BMC and BMD and fourth
lumbar BMD. The bone protective eﬀect of the combination
of soy with dried plum and FOS may be due to its ability
to decrease bone resorption, as shown by lower urinary
Dpd excretion. The dietary bioactive components caused a
reduction in bone resorption and maintained the increased
ratesofboneformationduetoovariectomy,therebyresulting
in a net bone gain in bone density. It is interesting to note
that whole-body BMD improvements were similar in the soy
protein diets combined with FOS alone (Ovx + soy + FOS)
and with both FOS and dried plum (Ovx + soy + plum +
FOS); however, there seems to be distinct diﬀerences in the
ability to improve bone health at diﬀerent sites. Soy plus FOS
seemedtoimproveBMDthegreatestattherightfemurwhile
greatest improvement in fourth lumbar BMD was seen in the
soy plus dried plum and FOS group.
In the present study, deterioration of Ovx-induced
trabecular microarchitecture was restored by adding dried
plum to a soy diet. Trabecular thickness increase due to Ovx
has been suggested to be a compensation for lost trabecular
connectivity [30]. Soy plus dried plum decreased Tb Th
to sham levels, ameliorating the deterioration, while soy +
FOS + plum decreased MS/BS to sham level. In addition,
any diet supplemented with FOS was able to restore bone
volume as percentage of tissue volume (BV/TV) to the
level of sham but was not signiﬁcantly diﬀerent from Ovx,
suggesting that this diet can prevent decline associated with
ovarian hormone deﬁciency. Histomorphometric changes
promoting skeletal strength via diet may aid in reducing
the incidence of osteoporotic fracture naturally and oﬀer
a promising alternative to those women who do not seek
conventional medicinal treatments.
Animals on a soy + FOS + plum diet showed an 8%
increase in fourth lumbar BMD and a 5% increase in both
whole-body and right femur BMD. These percent increases
are considered clinically relevant when results are compared
with studies using approved medications for treating osteo-
porosis. For instance, Ito et al. [31] showed that orally
administered alendronate improved lumbar BMD by 7.31%
after 10 weeks of treatment in 1-year-old rats. Furthermore,
Bourrin et al. [32] showed only a 4.2% increase in tibial
BMD. In the present study, treatment of soy+FOS+plum
additionally showed a 9.5% increase in Tb Th and 36%
increase in MS/BS compared with ovx animals. Our results6 Evidence-Based Complementary and Alternative Medicine
Table 4: Eﬀects of ovariectomy (Ovx) and various dietary treatments on serum and urinary parameters.
Parameters Sham-casein Ovx +
casein O v x+s o y O v x+s o y+p l u m O v x+s o y+F O S Ovx + soy +
plum + FOS
Serum
17-β estradiol (pg/mL) 21.9 ± 5.4a 7.2 ± 1.9b 6.4 ± 1.5b 5.3 ± 1.0b 3.8 ± 0.4b 4.9 ± 0.9b
ALP (U/L) 41.7 ± 4.3b 51.4 ± 4.3a,b 49.8 ± 4.1a,b 55.3 ± 4.1a 60.9 ± 4.4a 52.7 ± 4.3a,b
Urine Dpd 39.9 ± 8.9b 98.9 ± 25.8a 57.1 ± 3.7b 66.9 ± 17.8a,b 48.0 ± 3.2b 54.2 ± 3. 1b
(nmol/mmol creatinine)
Values are mean ± SE; n = 12. Within a row, values that do not share the same superscript letters are signiﬁcantly (P<. 05) diﬀerent from each other.
suggest that combining dried plum and FOS to a soy-based
diet showed results that are at least equivalent and may
surpass those of conventional medications.
The results from this study are in agreement with those
from our previous observations [12–14] that suggest the
eﬃcacy of dried plum exceeds that of soy protein and its
isoﬂavones. Our earlier animal data indicate that dried plum
not only protects against [12, 14] but more importantly
reverses bone loss in two separate models of osteopenia [13,
33, 34]. Our initial study [12] using Ovx rats indicated that
dried plum prevented the ovariectomy-induced reduction
in BMD of the femur and lumbar vertebra. In another
study in which Ovx rats were allowed to lose bone before
the initiation of treatment, dried plum was able to restore
BMD and bone strength to the level of sham-operated rats
[13]. Dried plum was also eﬃcacious in restoring the loss
in trabecular microarchitectural properties of the tibia and
the lumbar vertebra. Furthermore, we have also shown that
dried plum enhanced bone recovery during reambulation
following skeletal unloading and had comparable eﬀects to
PTH [33, 34]. Our positive animal ﬁndings on the eﬀect
of dried plum on bone were conﬁrmed by our short-term
clinical trial [15] in which dried plum supplementation
signiﬁcantlyincreasedindicesofboneformation(ALP,bone-
speciﬁc ALP levels and IGF-I) in postmenopausal women
while reducing bone resorption.
Relevant to the present study, it may be worth investi-
gating the mechanisms underlying the additive eﬀects of soy
with the diﬀerent bioactive compounds to provide an expla-
nation for these ﬁndings. Adding dried plum and/or FOS
to a soy-based diet can oﬀer improvements beyond that of
soy alone and results suggest that some of the combinations
may aﬀect diﬀerent areas with varying degrees. Therefore,
it is necessary to investigate if these bioactive compounds
either together or independently can also restore bone mass
in postmenopausal women. These positive eﬀects of dried
plum and FOS on biomarkers of bone metabolism have
resulted in an improvement of BMD in this animal model.
FOS and dried plum combined with soy in the diet provides
a valuable alternative to conventional osteoporosis therapies
due to their anti-resorptive and anabolic properties.
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